Scientists develop compound that could revolutionize tuberculosis treatment

Researchers have unveiled a promising new compound called CMX410 that targets a key enzyme in tuberculosis bacteria, potentially offering a powerful and effective treatment against this age-old disease. Tuberculosis remains one of humanity’s deadliest infectious threats, and CMX410’s…